Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Tumor necrosis factor-alpha")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 1464

  • Page / 59
Export

Selection :

  • and

Anti-TNF alpha : huit ans d'expérience cliniqueMASSON, Charles.Revue du rhumatisme (Ed. française). 2007, Vol 74, issn 1169-8330, 15 p., HS2Serial Issue

Éruptions psoriasiformes sous anti-TNFαSENESCHAL, Julien.La Revue du praticien. Médecine générale. 2014, Num 917, pp 206-207, issn 0989-2737, 2 p.Article

Forum in immunology. XXII: The multiple roles of tumour necrosis factorAnnales de l'Institut Pasteur. Immunologie. 1988, Vol 139, Num 3, pp 279-340, issn 0769-2625Article

Les nouveaux anti-TNFαWENDLING, D.La Lettre du rhumatologue. 2009, Num 356, pp 14-15, issn 0761-5027, 2 p., SUPArticle

Tumor necrosis factor alpha antagonist drugs and leishmaniasis in EuropeZANGER, P; KÖTTER, I; KREMSNER, P. G et al.Clinical microbiology and infection. 2012, Vol 18, Num 7, pp 670-676, issn 1198-743X, 7 p.Article

TNF-α antagonists beyond approved indications: stories of success and prospects for the futureKARAMPETSOU, M. P; LIOSSIS, S.-N. C; SFIKAKIS, P. P et al.QJM (Oxford. 1994. Print). 2010, Vol 103, Num 12, pp 917-928, issn 1460-2725, 12 p.Article

Is it safe to readminister tumor necrosis factor a antagonists following tuberculosis flare?ASLANIDIS, Spyros; PYRPASOPOULOU, Athina; DOUMA, Stella et al.Arthritis and rheumatism. 2008, Vol 58, Num 1, pp 327-328, issn 0004-3591, 2 p.Article

The induction of the TNFα death domain signaling pathway in Alzheimer's disease brainMING ZHAO; CRIBBS, David H; ANDERSON, Aileen J et al.Neurochemical research. 2003, Vol 28, Num 2, pp 307-318, issn 0364-3190, 12 p.Article

Quelles sont les nouvelles des anti-TNF dans le traitement de la PR ?DEVAUCHELLE-PENSEC, Valérie.La Lettre du rhumatologue. 2012, Num 379-80, pp 3-11, issn 0761-5027, 9 p., SUP1Article

Adverse Cutaneous Reactions Induced by TNF-α Antagonist TherapyBORRAS-BLASCO, Joaquin; NAVARRO-RUIZ, Andrés; BORRAS, Consuelo et al.Southern medical journal (Birmingham, Ala. Print). 2009, Vol 102, Num 11, pp 1133-1140, issn 0038-4348, 8 p.Article

Les anti-TNF en 2009 Compte-rendu du congrès de la SFRGAUJOUX-VIALA, Cécile; LEQUERRE, Thierry.La Lettre du rhumatologue. 2009, Num JUIN, pp 2-11, issn 0761-5027, 10 p., NS-INFOS-CONGRESArticle

ACNEIFORM ERUPTION FOLLOWING ANTI-TNF-ALPHA TREATMENT : A REPORT OF THREE CASESSUN, Grace; WASKO, Carina A; HSU, Sylvia et al.Journal of drugs in dermatology. 2008, Vol 7, Num 1, pp 69-71, issn 1545-9616, 3 p.Article

Anti-inflammatory and cartilage-protecting effects of an intra-articularly injected anti-TNFα single-chain Fv antibody (ESBA105) designed for local therapeutic useURECH, D. M; FEIGE, U; EWERT, S et al.Annals of the rheumatic diseases. 2010, Vol 69, Num 2, pp 443-449, issn 0003-4967, 7 p.Article

Manifestations cutanées observées au cours d'un traitement par anti-TNF alpha : 11 observations = Cutaneous manifestations during treatment with TNF-alpha blockers : 11 casesLEBAS, D; STAUMONT-SALLE, D; SOLAU-GERVAIS, E et al.Annales de dermatologie et de vénéréologie. 2007, Vol 134, Num 4, pp 337-342, issn 0151-9638, 6 p., CAH1Article

Tumor necrosis factor-alpha as a potential therapeutic target in idiopathic inflammatory myopathiesSTIIBGEN, Joerg-Patrick.Journal of neurology. 2011, Vol 258, Num 6, pp 961-970, issn 0340-5354, 10 p.Article

Role of mannose receptor in oligochitosan-mediated stimulation of macrophage functionYANPING HAN; LUHANG ZHAO; ZHIJUN YU et al.International immunopharmacology. 2005, Vol 5, Num 10, pp 1533-1542, issn 1567-5769, 10 p.Article

The role of tumor necrosis factor-alpha and other cytokines in depression: what dermatologists should knowKANNAN, Swati; HELLER, Misha M; LEE, Eric S et al.Journal of dermatological treatment. 2013, Vol 24, Num 2, pp 148-152, issn 0954-6634, 5 p.Article

Effects of three anti-TNF-α drugs : Etanercept, infliximab and pirfenidone on release of TNF-α in medium and TNF-α associated with the cell in vitroGRATTENDICK, K. J; NAKASHIMA, J. M; FENG, L et al.International immunopharmacology. 2008, Vol 8, Num 5, pp 679-687, issn 1567-5769, 9 p.Article

Effets paradoxaux des biomédicaments anti-TNFα = Paradoxical effects of anti-TNF-α biodrugsWENDLING, D; BRINSTER, A; SONDAG, M et al.La Lettre du rhumatologue. 2014, Num 402-03, pp 28-31, issn 0761-5027, 4 p.Article

Pityriasis rubra pilaris types 1 and 2: different responses to treatment with TNF-alpha antagonistsVUJIC, Igor; RICHTER, Leo; BARTSCH, Katrin et al.EJD. European journal of dermatology. 2013, Vol 23, Num 6, pp 895-896, issn 1167-1122, 2 p.Article

Efficacité des anti-TNF chez les patients atteints de spondyloarthropathie en l'absence de signes à l'imagerieBISSON-VAIVRE, Aurélia; ALCAIX, Didier; ZARNITSKY, Charles et al.Revue du rhumatisme (Ed. française). 2013, Vol 80, Num 3, pp 250-256, issn 1169-8330, 7 p.Article

ThalidomidePROMMER, Eric E; TWYCROSS, Robert; MIHALYO, Mary et al.Journal of pain and symptom management. 2011, Vol 41, Num 1, pp 140-145, issn 0885-3924, 6 p.Article

Anti-TNFα therapy—killing two birds with one stone?ARIF, Sefina; COX, Patricia; AFZALI, Behdad et al.Lancet (British edition). 2010, Vol 375, Num 9733, issn 0140-6736, p. 2278Article

Tumor Necrosis Factor-Alpha Levels After Surgical Anti-Infective Mechanical Therapy for Peri-Implantitis : A 12-Month Follow-DpCUTRIM DE MENDONCA, Adriana; SANTOS, Vanessa Renata; CESAR, Joao Batista et al.Journal of periodontology (1970). 2009, Vol 80, Num 4, pp 693-699, issn 0022-3492, 7 p.Article

Immunogénicité des anti-TNFαSARAUX, A.La Lettre du rhumatologue. 2007, Num 336, pp 3-4, issn 0761-5027, 2 p., SUPArticle

  • Page / 59